Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Rheumatology

How do you treat an active FMF attack?

At a Glance

Do not take extra colchicine to stop an active Familial Mediterranean Fever (FMF) attack. Colchicine prevents flares but cannot stop them once they begin. Extra doses risk dangerous toxicity. Instead, manage symptoms with rest, hydration, and doctor-approved NSAIDs while maintaining your daily dose.

When you feel the familiar pain and fever of a Familial Mediterranean Fever (FMF) attack starting, your first instinct might be to take extra colchicine to stop it. Do not take extra colchicine during an active flare. Taking an additional or “on-demand” dose of colchicine will not stop or shorten an attack that has already started [1][2]. Colchicine is a preventative medication, not a rescue treatment [3][4]. Taking more than your prescribed daily dose can lead to dangerous toxicity. Instead, you should continue your regular daily dose and manage the acute symptoms using supportive therapies like rest, hydration, and pain relievers [1][5].

Why Extra Colchicine Doesn’t Work for Flares

Colchicine is the cornerstone of FMF management, but its job is to prevent attacks from happening and to protect you from long-term complications like AA amyloidosis (a buildup of abnormal proteins in your organs) [3][6].

  • It is not a rescue drug: Medical guidelines emphasize that colchicine should not be used as an “on-demand” therapy for acute flares [1][2].
  • Risk of toxicity: Increasing your dose without medical supervision does not relieve symptoms and puts you at a high risk for colchicine toxicity, which can cause dangerous and severe side effects [2].
  • Maintain your routine: The best thing you can do with your colchicine during an attack is simply to keep taking your prescribed daily maintenance dose [1][7]. Strict, long-term adherence to this daily dose is the most effective way to prevent future attacks [7][8].

Managing Symptoms During an Active Attack

Because you cannot stop an attack once it begins, the goal of treatment during a flare is to keep you as comfortable as possible for the 1 to 3 days it typically takes to pass. This is called supportive care [1][2].

  • Rest: Your body is fighting systemic inflammation [8]. Rest as much as possible until the fever and pain subside.
  • Hydration: Drink plenty of fluids, especially if you have a fever.
  • Pain Management: Over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen are often recommended to help control the pain and inflammation associated with serositis (the painful inflammation of the lining of your abdomen, chest, or joints) [5][9]. Always check with your doctor before starting NSAIDs, as they may not be safe if you have kidney issues. If over-the-counter pain relievers are not enough to manage your severe pain, contact your doctor for guidance rather than adjusting your medications on your own.
  • Avoid Corticosteroids: It is worth noting that prescription steroid medications (like prednisone) are not part of the standard care for treating or preventing acute FMF attacks [10].

When to Contact Your Doctor

While most FMF flares pass with supportive care, you should contact your doctor if your attack lasts longer than 3 to 4 days, or if the pain is completely different from your typical flares. Because FMF abdominal pain can mimic surgical emergencies like appendicitis, you should seek immediate medical attention if your symptoms feel unusually severe or different than your usual pattern.

Watch for Colchicine Resistance

If you are experiencing frequent FMF attacks (such as one or more attacks per month) despite taking your daily colchicine exactly as prescribed, do not try to manage this by taking extra pills. You may be experiencing colchicine resistance, which means your body is still having inflammatory attacks even at the maximum tolerated dose of colchicine [1][11][12].

If this is happening, talk to your doctor. Medical guidelines recommend the use of IL-1 inhibitors (biologic medications like canakinumab or anakinra) for patients who are resistant to or cannot tolerate colchicine [11][13][14]. These medications target the specific inflammatory pathways involved in FMF to help control the disease and prevent flares [15][16].

Common questions in this guide

Should I take extra colchicine to stop an FMF attack?
No, you should never take an extra or on-demand dose of colchicine during an active flare. Colchicine is a preventative medication that cannot stop an attack once it has started. Taking more than your prescribed daily dose puts you at a high risk for dangerous toxicity.
How long does an FMF flare usually last?
A typical Familial Mediterranean Fever attack lasts between 1 to 3 days. During this time, the goal is to manage symptoms with supportive care like rest, hydration, and pain relievers until the flare passes.
What medications can I take for pain during an FMF flare?
Over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen are typically used to control pain and inflammation during a flare. Always check with your doctor before taking NSAIDs to make sure they are safe for your kidneys.
When should I seek medical attention for an FMF attack?
You should contact your doctor or go to the emergency room if your attack lasts longer than 3 to 4 days, or if the abdominal pain feels unusually severe or different from your typical flares. FMF pain can sometimes mimic surgical emergencies like appendicitis.
What if I keep having FMF attacks while taking daily colchicine?
If you are having one or more attacks per month despite taking your colchicine exactly as prescribed, you may have colchicine resistance. You should talk to your doctor, who may recommend biologic medications called IL-1 inhibitors to help control the inflammation.

Questions for Your Doctor

5 questions

  • What is my specific maximum tolerated dose of colchicine, and how do we know if we've reached it?
  • If over-the-counter NSAIDs like ibuprofen do not control the severe pain during my flares, what other pain management options are safe for me to use?
  • At what point—such as a specific number of attacks per year—do you consider my current colchicine dose to be failing or resistant?
  • Are my kidneys currently healthy enough to safely use NSAIDs during my attacks?
  • If my abdominal pain feels different than my typical FMF flares, what specific symptoms should prompt me to go to the emergency room?

Questions for You

3 questions

  • How frequently am I currently experiencing attacks while strictly taking my daily preventative dose of colchicine?
  • How long do my typical FMF flares usually last, and what does the pain normally feel like compared to an unusual pain?
  • What non-medication strategies, such as resting in a specific position or using heat, have I found most helpful for coping with pain during an active flare?

References

References (16)
  1. 1

    French protocol for the diagnosis and management of familial Mediterranean fever.

    Georgin-Lavialle S, Savey L, Cuisset L, et al.

    La Revue de medecine interne 2023; (44(11)):602-616 doi:10.1016/j.revmed.2023.10.441.

    PMID: 37903671
  2. 2

    Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.

    Soriano A, Soriano M, Espinosa G, et al.

    Frontiers in immunology 2020; (11()):865 doi:10.3389/fimmu.2020.00865.

    PMID: 32655539
  3. 3

    An Update on Familial Mediterranean Fever.

    Lancieri M, Bustaffa M, Palmeri S, et al.

    International journal of molecular sciences 2023; (24(11)) doi:10.3390/ijms24119584.

    PMID: 37298536
  4. 4

    Colchicine--Update on mechanisms of action and therapeutic uses.

    Leung YY, Yao Hui LL, Kraus VB

    Seminars in arthritis and rheumatism 2015; (45(3)):341-50.

    PMID: 26228647
  5. 5

    The unsolved mystery of MEFV variants variable expressivity in Familial Mediterranean Fever.

    Stella A, Portincasa P

    Internal and emergency medicine 2022; (17(5)):1255-1259 doi:10.1007/s11739-022-03027-4.

    PMID: 35809153
  6. 6

    Colchicine-Treated Familial Mediterranean Fever Patients Are Associated With a Lower Prevalence of Mitral Annular Calcification.

    Cüre O, Durak H, Çetin M, et al.

    Echocardiography (Mount Kisco, N.Y.) 2026; (43(3)):e70415 doi:10.1111/echo.70415.

    PMID: 41758070
  7. 7

    Familial Mediterranean fever in childhood: a single-center experience.

    Barut K, Sahin S, Adrovic A, et al.

    Rheumatology international 2018; (38(1)):67-74 doi:10.1007/s00296-017-3796-0.

    PMID: 28828621
  8. 8

    Familial Mediterranean fever: overview of pathogenesis, clinical features and management.

    Migita K, Asano T, Sato S, et al.

    Immunological medicine 2018; (41(2)):55-61 doi:10.1080/13497413.2018.1481579.

    PMID: 30938266
  9. 9

    Cardiac repolarization abnormalities in children with familial Mediterranean fever.

    Farag Y, Sayed S, Mostafa FA, et al.

    Pediatric rheumatology online journal 2022; (20(1)):38 doi:10.1186/s12969-022-00696-5.

    PMID: 35606812
  10. 10

    Necessity of Utilizing Physiological Glucocorticoids for Managing Familial Mediterranean Fever.

    Ashida K, Terada E, Nagayama A, et al.

    The American journal of case reports 2020; (21()):e920983 doi:10.12659/AJCR.920983.

    PMID: 32203056
  11. 11

    Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

    De Benedetti F, Gattorno M, Anton J, et al.

    The New England journal of medicine 2018; (378(20)):1908-1919 doi:10.1056/NEJMoa1706314.

    PMID: 29768139
  12. 12

    A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry.

    Batu ED, Şener S, Arslanoglu Aydin E, et al.

    Rheumatology (Oxford, England) 2024; (63(3)):791-797 doi:10.1093/rheumatology/kead242.

    PMID: 37228026
  13. 13

    Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.

    Yildirim D, Kardas RC, Gun M, et al.

    International immunopharmacology 2024; (128()):111491 doi:10.1016/j.intimp.2024.111491.

    PMID: 38241844
  14. 14

    [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].

    Shouval R, Livneh A, Ben-Zvi I

    Harefuah 2015; (154(11)):716-9, 741.

    PMID: 26821505
  15. 15

    Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab.

    Druyan A, Giat E, Livneh A, et al.

    Clinical and experimental rheumatology 2021; (39 Suppl 132(5)):75-79 doi:10.55563/clinexprheumatol/rrr9zd.

    PMID: 34369359
  16. 16

    Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.

    Sag E, Akal F, Atalay E, et al.

    Rheumatology (Oxford, England) 2020; (59(11)):3324-3329 doi:10.1093/rheumatology/keaa121.

    PMID: 32306038

This page provides educational information on managing Familial Mediterranean Fever attacks. Always consult your doctor before taking new medications or adjusting your prescribed colchicine dose.

Get notified when new evidence is published on Familial Mediterranean fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.